Skip to main content

Advertisement

Table 2 Clinical and nutritional status of patients at baseline

From: Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial

  Groups
  Control (n = 25) RUTF (n = 26) p
Age (y) 42 ± 12 40 ± 12 0.800
Female, % (n) 52 (22) 86 (13) 0.090
HIV-1, % (n) 84 (21) 92 (24) 0.874
ART, % (n) 76 (19) 73 (19) 1.000
CD4 count), 128 ± 148 109 ± 165 0.082
<200 cells/μL, % (n) 84 (19) 81.7 (21) 0.725.
Weight (kg) 51.4 ± 9.8 47.1 ± 9.4 0.121
Height (m) 1.72 ± 0.08 1.66 ± 0.50 0.006
BMI (kg/m2) 17.5 ± 0.6 16.7 ± 0.6 0.711
< 16 kg/m 2 , % (n) 24 (8) 34 (11) 0.886
TBW (kg) 8.1 ± 2.7 7.7 ± 2.8 0.121
FFM (kg) 11.1 ± 0.4 10.6 ± 0.4 0.121
BF (kg) 39.4 ± 1.2 37.8 ± 1.2 0.651
% BF 78.0 78.2 0.789
Zinc (μg/dL) 68.1 ± 29.8 68.7 ± 32.4 0.992
 Zinc deficiency, % (n) 64 (16) 54 (14) 0.765
Hb (μg/dL) 8.5 ± 2.0 8.4 ± 2.2 0.084
 Anemia, % (n) 96 (24) 92 (24) 1.000
Chronic infection, % (n) 32 (8) 31 (8) 1.000
  1. Zinc deficiency: women, PZ <70 g/dL (morning fasting) and PZ < 66 mg/dL (morning nonfasting); men, PZ <74 g/dL (morning fasting) and PZ <70 mg/dL (morning nonfasting)
  2. Anemia: women, Hb <12 μg/dL and men Hb <14 μg/dL
  3. Chronic infection: CRP < 5 mg/L and AGP ≥ 1 g/L